Event: ASCO 2024

Lung Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Joshua Sabari

ASCO 2024: key updates in gastric, colorectal, and hepatocellular cancer treatments

Highlights in skin cancer at ASCO 2024

GI ASCO 2024 Highlights with Dr. Pamela Kunz – CheckMate 8HW, EMERALD-1, NETTER-2

GI Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Mark Lewis

ASCO 2024 - Ouverture du congrès et point sur les actualités à suivre

Gustave Roussy à l'ASCO 2024 - Tumeurs digestives

ASCO 2024 | Neue Therapieoptionen bei Brustkrebs: Ergebnisse der DB06-Studie

Trials in EGFR Mutated NSCLC: Flaura2 and Mariposa- 2024 Leading Developments in Lung Cancer

Update from ASCO 2024

Report Back from ASCO 2024: Latest Updates on Metastatic Breast Cancer (MBC)

GI ASCO 2024 Recap

Breast Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Erika Hamilton

Emerging therapies in gynecologic oncology at ASCO 2024

ASCO 2024 | Neues zum Endometriumkarzinom (Gebärmutterschleimhautkrebs)

Radiation-Oncology changing clinical trials from ASCO Annual Meeting 2024

ASCO 2024 Exclusive Executive KOL Highlights

Gustave Roussy à l'ASCO 2024 - Tumeurs thoraciques

Gustave Roussy à l'ASCO 2024 - Tumeurs du sein

ASCO 2024 | Hirnmetastasen und Metastasierung der Hirnhäute bei Brustkrebs

Gustave Roussy à l'ASCO 2024 - David PLANCHARD

ASCO 2024: Advances in Melanoma and Related Cancers

2024 ASCO Highlights

ASCO 2024: Dr. Fred Locke Discusses Immunotherapy